Although our results do not suggest that CP-870,893 and CpG ODN 2006 are synergistic, these results do suggest that the inclusion of TLR9 stimulation is important for optimal activation of naïve B cells, a finding of particular importance for patients with advanced cancer in whom naïve B cells dominate the peripheral B cell compartment [24]. Here, TLR9 is linked to cancer.